Latest Commercialization News

IPB Petroleum has signed a binding terms sheet to acquire a significant acreage position in Alaska’s National Petroleum Reserve, including the Umiat oil field, while raising $1.27 million to fund exploration and development studies.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.

Pro Medicus has disclosed a contained data breach involving unauthorized access to a single employee email inbox, with limited exposure of personal information from around 100 current and former employees.

6K Additive has landed a landmark US$27.4 million loan from the US Export-Import Bank, partnering with the Department of War to fund a major expansion in Pennsylvania that will quintuple powder production capacity and create over 50 new jobs.

BetMakers Technology Group has inked a pivotal five-year exclusive agreement with Betfair Australia to provide the full wagering technology stack for CrownBet's launch, marking a major milestone for its Apollo platform.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

BrainChip Holdings has closed its Share Purchase Plan with subscriptions exceeding the $2 million target by nearly $1 million, complementing a recent $35 million placement. The Board’s decision to accept all applications reflects robust shareholder confidence.

Pacgold has finalized its acquisition of the White Dam Gold Operation in South Australia, setting the stage for a near-term production restart with modest capital investment. The move complements its Queensland projects and offers a clear path to cash flow.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Lotus Resources reports promising progress at its Kayelekera uranium mine, targeting steady state production by Q1 2026 despite recent sulphuric acid supply constraints. The company is addressing supply issues with new sourcing and an on-schedule acid plant rebuild.

New Murchison Gold Limited reports robust November production at Crown Prince Gold Mine, with ore sales exceeding expectations and a $41.6 million payment received from Westgold Resources.

AdAlta Limited has received a $0.78 million Research and Development Tax Incentive refund for FY2025, using part of it to repay a Radium Capital loan and strengthening its cash position as it nears a key licensing milestone.